2AA6 - Header Asymmetric Unit

HEADER TRANSCRIPTION 13-JUL-05 2AA6

TITLE MINERALOCORTICOID RECEPTOR S810L MUTANT WITH BOUND TITLE 2 PROGESTERONE

COMPND MOL_ID: 1; COMPND 2 MOLECULE: MINERALOCORTICOID RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: MR; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR3C2, MCR, MLR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PHIS GST

KEYWDS MINERALOCORTICOID RECEPTOR, MR, NUCLEAR RECEPTOR, STEROID KEYWDS 2 RECEPTOR, PROGESTERONE, HYPERTENSION, TRANSCRIPTION

EXPDTA X-RAY DIFFRACTION

AUTHOR R.K.BLEDSOE,K.P.MADAUSS,J.A.HOLT,C.J.APOLITO,M.H.LAMBERT, AUTHOR 2 K.H.PEARCE,T.B.STANLEY,E.L.STEWART,R.P.TRUMP,T.M.WILLSON, AUTHOR 3 S.P.WILLIAMS

REVDAT 3 24-FEB-09 2AA6 1 VERSN REVDAT 2 13-SEP-05 2AA6 1 JRNL REVDAT 1 26-JUL-05 2AA6 0

JRNL AUTH R.K.BLEDSOE,K.P.MADAUSS,J.A.HOLT,C.J.APOLITO, JRNL AUTH 2 M.H.LAMBERT,K.H.PEARCE,T.B.STANLEY,E.L.STEWART, JRNL AUTH 3 R.P.TRUMP,T.M.WILLSON,S.P.WILLIAMS JRNL TITL A LIGAND-MEDIATED HYDROGEN BOND NETWORK REQUIRED JRNL TITL 2 FOR THE ACTIVATION OF THE MINERALOCORTICOID JRNL TITL 3 RECEPTOR JRNL REF J.BIOL.CHEM. V. 280 31283 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15967794 JRNL DOI 10.1074/JBC.M504098200

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 48336 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3373 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4080 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 324 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01500 REMARK 3 B22 (A**2) : 0.00200 REMARK 3 B33 (A**2) : 0.01200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 BOND ANGLES (DEGREES) : 1.36 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : PRG.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 2AA6 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JUL-04. REMARK 100 THE RCSB ID CODE IS RCSB033677.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUL-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : SAGITALLY FOCUSSED SI REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48587 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.38900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: MR LBD REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH7.5, 0.9M LI2SO4, 2% REMARK 280 PEG 2KMME, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.07750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 85.92250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.83800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 85.92250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.07750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.83800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC REMARK 300 ASYMMETRIC UNIT WHICH CONSISTS OF 2 CHAIN(S). THE BIOLOGICAL REMARK 300 UNIT IS A DIMER, BUT THE DIMER IN THE CRYSTAL IS IRRELEVANT REMARK 300 BIOLOGICALLY. THE BIOLOGICAL DIMER IS CURRENTLY UNKNOWN.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 710 REMARK 465 SER A 711 REMARK 465 ALA A 712 REMARK 465 PRO A 713 REMARK 465 ALA A 714 REMARK 465 LYS A 715 REMARK 465 GLU A 716 REMARK 465 PRO A 717 REMARK 465 SER A 718 REMARK 465 VAL A 719 REMARK 465 ASN A 720 REMARK 465 THR A 721 REMARK 465 PRO A 911 REMARK 465 ARG A 983 REMARK 465 LYS A 984 REMARK 465 GLY B 710 REMARK 465 SER B 711 REMARK 465 ALA B 712 REMARK 465 PRO B 713 REMARK 465 ALA B 714 REMARK 465 LYS B 715 REMARK 465 GLU B 716 REMARK 465 PRO B 717 REMARK 465 SER B 718 REMARK 465 VAL B 719 REMARK 465 ASN B 720 REMARK 465 THR B 721 REMARK 465 LYS B 909 REMARK 465 CYS B 910 REMARK 465 ARG B 983 REMARK 465 LYS B 984

REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 723 CG CD1 CD2 REMARK 470 LEU A 727 CG CD1 CD2 REMARK 470 ARG A 732 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 748 CG CD OE1 OE2 REMARK 470 ARG A 771 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 791 CG CD CE NZ REMARK 470 GLU A 796 CG CD OE1 OE2 REMARK 470 LYS A 820 CG CD CE NZ REMARK 470 GLN A 825 CG CD OE1 NE2 REMARK 470 ARG A 861 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 883 CG CD CE NZ REMARK 470 LYS A 901 CG CD CE NZ REMARK 470 LYS A 905 CG CD CE NZ REMARK 470 LYS A 909 CG CD CE NZ REMARK 470 CYS A 910 SG REMARK 470 ASN A 912 CG OD1 ND2 REMARK 470 GLN A 916 CG CD OE1 NE2 REMARK 470 LYS A 926 CG CD CE NZ REMARK 470 GLU A 940 CG CD OE1 OE2 REMARK 470 LEU B 727 CG CD1 CD2 REMARK 470 ARG B 732 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 771 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 791 CG CD CE NZ REMARK 470 ASN B 792 CG OD1 ND2 REMARK 470 GLU B 796 CG CD OE1 OE2 REMARK 470 LYS B 820 CG CD CE NZ REMARK 470 GLU B 847 CG CD OE1 OE2 REMARK 470 ARG B 861 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 883 CG CD CE NZ REMARK 470 LYS B 901 CG CD CE NZ REMARK 470 ARG B 904 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 905 CG CD CE NZ REMARK 470 PRO B 911 CG CD REMARK 470 GLN B 916 CG CD OE1 NE2 REMARK 470 LYS B 926 CG CD CE NZ REMARK 470 HIS B 950 CG ND1 CD2 CE1 NE2

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 884 ND2 ASN A 975 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 884 -72.56 -53.93 REMARK 500 REMARK 500 REMARK: NULL

REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 235 DISTANCE = 5.20 ANGSTROMS REMARK 525 HOH A 240 DISTANCE = 5.43 ANGSTROMS REMARK 525 HOH B 237 DISTANCE = 5.20 ANGSTROMS REMARK 525 HOH A 248 DISTANCE = 5.08 ANGSTROMS REMARK 525 HOH B 249 DISTANCE = 5.55 ANGSTROMS REMARK 525 HOH A 261 DISTANCE = 5.41 ANGSTROMS REMARK 525 HOH A 288 DISTANCE = 5.57 ANGSTROMS

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STR A 401 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STR B 402

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AA2 RELATED DB: PDB REMARK 900 MR WITH BOUND ALDOSTERONE REMARK 900 RELATED ID: 2AA5 RELATED DB: PDB REMARK 900 MR WITH BOUND PROGESTERONE REMARK 900 RELATED ID: 2AA7 RELATED DB: PDB REMARK 900 RELATED ID: 2AAR RELATED DB: PDB REMARK 900 RELATED ID: 2AAX RELATED DB: PDB REMARK 900 RELATED ID: 2AB2 RELATED DB: PDB

DBREF 2AA6 A 712 984 UNP P08235 MCR_HUMAN 712 984 DBREF 2AA6 B 712 984 UNP P08235 MCR_HUMAN 712 984

SEQADV 2AA6 GLY A 710 UNP P08235 CLONING ARTIFACT SEQADV 2AA6 SER A 711 UNP P08235 CLONING ARTIFACT SEQADV 2AA6 SER A 808 UNP P08235 CYS 808 ENGINEERED SEQADV 2AA6 LEU A 810 UNP P08235 SER 810 ENGINEERED SEQADV 2AA6 GLY B 710 UNP P08235 CLONING ARTIFACT SEQADV 2AA6 SER B 711 UNP P08235 CLONING ARTIFACT SEQADV 2AA6 SER B 808 UNP P08235 CYS 808 ENGINEERED SEQADV 2AA6 LEU B 810 UNP P08235 SER 810 ENGINEERED

SEQRES 1 A 275 GLY SER ALA PRO ALA LYS GLU PRO SER VAL ASN THR ALA SEQRES 2 A 275 LEU VAL PRO GLN LEU SER THR ILE SER ARG ALA LEU THR SEQRES 3 A 275 PRO SER PRO VAL MET VAL LEU GLU ASN ILE GLU PRO GLU SEQRES 4 A 275 ILE VAL TYR ALA GLY TYR ASP SER SER LYS PRO ASP THR SEQRES 5 A 275 ALA GLU ASN LEU LEU SER THR LEU ASN ARG LEU ALA GLY SEQRES 6 A 275 LYS GLN MET ILE GLN VAL VAL LYS TRP ALA LYS VAL LEU SEQRES 7 A 275 PRO GLY PHE LYS ASN LEU PRO LEU GLU ASP GLN ILE THR SEQRES 8 A 275 LEU ILE GLN TYR SER TRP MET SER LEU LEU SER PHE ALA SEQRES 9 A 275 LEU SER TRP ARG SER TYR LYS HIS THR ASN SER GLN PHE SEQRES 10 A 275 LEU TYR PHE ALA PRO ASP LEU VAL PHE ASN GLU GLU LYS SEQRES 11 A 275 MET HIS GLN SER ALA MET TYR GLU LEU CYS GLN GLY MET SEQRES 12 A 275 HIS GLN ILE SER LEU GLN PHE VAL ARG LEU GLN LEU THR SEQRES 13 A 275 PHE GLU GLU TYR THR ILE MET LYS VAL LEU LEU LEU LEU SEQRES 14 A 275 SER THR ILE PRO LYS ASP GLY LEU LYS SER GLN ALA ALA SEQRES 15 A 275 PHE GLU GLU MET ARG THR ASN TYR ILE LYS GLU LEU ARG SEQRES 16 A 275 LYS MET VAL THR LYS CYS PRO ASN ASN SER GLY GLN SER SEQRES 17 A 275 TRP GLN ARG PHE TYR GLN LEU THR LYS LEU LEU ASP SER SEQRES 18 A 275 MET HIS ASP LEU VAL SER ASP LEU LEU GLU PHE CYS PHE SEQRES 19 A 275 TYR THR PHE ARG GLU SER HIS ALA LEU LYS VAL GLU PHE SEQRES 20 A 275 PRO ALA MET LEU VAL GLU ILE ILE SER ASP GLN LEU PRO SEQRES 21 A 275 LYS VAL GLU SER GLY ASN ALA LYS PRO LEU TYR PHE HIS SEQRES 22 A 275 ARG LYS SEQRES 1 B 275 GLY SER ALA PRO ALA LYS GLU PRO SER VAL ASN THR ALA SEQRES 2 B 275 LEU VAL PRO GLN LEU SER THR ILE SER ARG ALA LEU THR SEQRES 3 B 275 PRO SER PRO VAL MET VAL LEU GLU ASN ILE GLU PRO GLU SEQRES 4 B 275 ILE VAL TYR ALA GLY TYR ASP SER SER LYS PRO ASP THR SEQRES 5 B 275 ALA GLU ASN LEU LEU SER THR LEU ASN ARG LEU ALA GLY SEQRES 6 B 275 LYS GLN MET ILE GLN VAL VAL LYS TRP ALA LYS VAL LEU SEQRES 7 B 275 PRO GLY PHE LYS ASN LEU PRO LEU GLU ASP GLN ILE THR SEQRES 8 B 275 LEU ILE GLN TYR SER TRP MET SER LEU LEU SER PHE ALA SEQRES 9 B 275 LEU SER TRP ARG SER TYR LYS HIS THR ASN SER GLN PHE SEQRES 10 B 275 LEU TYR PHE ALA PRO ASP LEU VAL PHE ASN GLU GLU LYS SEQRES 11 B 275 MET HIS GLN SER ALA MET TYR GLU LEU CYS GLN GLY MET SEQRES 12 B 275 HIS GLN ILE SER LEU GLN PHE VAL ARG LEU GLN LEU THR SEQRES 13 B 275 PHE GLU GLU TYR THR ILE MET LYS VAL LEU LEU LEU LEU SEQRES 14 B 275 SER THR ILE PRO LYS ASP GLY LEU LYS SER GLN ALA ALA SEQRES 15 B 275 PHE GLU GLU MET ARG THR ASN TYR ILE LYS GLU LEU ARG SEQRES 16 B 275 LYS MET VAL THR LYS CYS PRO ASN ASN SER GLY GLN SER SEQRES 17 B 275 TRP GLN ARG PHE TYR GLN LEU THR LYS LEU LEU ASP SER SEQRES 18 B 275 MET HIS ASP LEU VAL SER ASP LEU LEU GLU PHE CYS PHE SEQRES 19 B 275 TYR THR PHE ARG GLU SER HIS ALA LEU LYS VAL GLU PHE SEQRES 20 B 275 PRO ALA MET LEU VAL GLU ILE ILE SER ASP GLN LEU PRO SEQRES 21 B 275 LYS VAL GLU SER GLY ASN ALA LYS PRO LEU TYR PHE HIS SEQRES 22 B 275 ARG LYS

HET STR A 401 23 HET STR B 402 23

HETNAM STR PROGESTERONE

FORMUL 3 STR 2(C21 H30 O2) FORMUL 5 HOH *324(H2 O)

HELIX 1 1 SER A 728 THR A 735 1 8 HELIX 2 2 SER A 737 GLU A 746 1 10 HELIX 3 3 THR A 761 VAL A 786 1 26 HELIX 4 4 GLY A 789 LEU A 793 5 5 HELIX 5 5 PRO A 794 ASN A 823 1 30 HELIX 6 6 ASN A 836 SER A 843 1 8 HELIX 7 7 MET A 845 GLN A 863 1 19 HELIX 8 8 THR A 865 LEU A 878 1 14 HELIX 9 9 SER A 888 VAL A 907 1 20 HELIX 10 10 ASN A 913 GLU A 948 1 36 HELIX 11 11 GLU A 948 LYS A 953 1 6 HELIX 12 12 PRO A 957 SER A 973 1 17 HELIX 13 13 SER B 728 THR B 735 1 8 HELIX 14 14 SER B 737 GLU B 746 1 10 HELIX 15 15 THR B 761 VAL B 786 1 26 HELIX 16 16 GLY B 789 LEU B 793 5 5 HELIX 17 17 PRO B 794 ASN B 823 1 30 HELIX 18 18 ASN B 836 SER B 843 1 8 HELIX 19 19 MET B 845 GLN B 863 1 19 HELIX 20 20 THR B 865 LEU B 878 1 14 HELIX 21 21 SER B 888 VAL B 907 1 20 HELIX 22 22 ASN B 913 GLU B 948 1 36 HELIX 23 23 GLU B 948 LYS B 953 1 6 HELIX 24 24 PRO B 957 SER B 973 1 17

SHEET 1 A 2 LEU A 827 ALA A 830 0 SHEET 2 A 2 LEU A 833 PHE A 835 -1 O PHE A 835 N LEU A 827 SHEET 1 B 2 THR A 880 PRO A 882 0 SHEET 2 B 2 ALA A 976 PRO A 978 -1 O LYS A 977 N ILE A 881 SHEET 1 C 2 LEU B 827 ALA B 830 0 SHEET 2 C 2 LEU B 833 PHE B 835 -1 O PHE B 835 N LEU B 827 SHEET 1 D 2 THR B 880 PRO B 882 0 SHEET 2 D 2 ALA B 976 PRO B 978 -1 O LYS B 977 N ILE B 881

SITE 1 AC1 11 LEU A 769 ASN A 770 ALA A 773 GLN A 776 SITE 2 AC1 11 LEU A 810 ARG A 817 PHE A 829 MET A 845 SITE 3 AC1 11 PHE A 941 CYS A 942 THR A 945 SITE 1 AC2 10 HOH B 2 LEU B 769 ASN B 770 GLN B 776 SITE 2 AC2 10 LEU B 810 ARG B 817 PHE B 829 PHE B 941 SITE 3 AC2 10 CYS B 942 THR B 945

CRYST1 42.155 89.676 171.845 90.00 90.00 90.00 P 21 21 21 8

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.023722 0.000000 0.000000 0.00000

SCALE2 0.000000 0.011151 0.000000 0.00000

SCALE3 0.000000 0.000000 0.005819 0.00000